Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2004
Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte
N Mounier, C Gisselbrecht, J Brière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2004
All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
N Mounier, C Gisselbrecht, J Brière, et al.
European Journal of Nuclear Medicine
|
February 7, 2001
Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy
C Delcambre, O Reman, M Henry-Amar, et al.
The Journal of Rheumatology
|
August 26, 1998
A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis
D Wendling, E Racadot, J Wijdenes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2009
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
E Terpos, O Sezer, P I Croucher, et al.
La Revue De Medecine Interne
|
August 11, 2015
[Pomalidomide for multiple myeloma]
G Fouquet, M Macro, O Decaux, et al.
Annals of Hematology
|
June 10, 2023
Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study
M Macro, C Hulin, L Vincent, et al.
British Journal of Haematology
|
September 14, 2024
Teclistamab for relapsed refractory multiple myeloma patients on dialysis
P Lebreton, F Lachenal, S Bouillie, et al.
Leukemia
|
July 30, 2011
Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience
H Avet-Loiseau, M Roussel, L Campion, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 27, 2024
Real-Life Management of Patients Aged 80 Years Old and Over With Multiple Myeloma: Results of the EMMY Cohort
T Chalopin, M Macro, O Decaux, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2004
Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte
N Mounier, C Gisselbrecht, J Brière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2004
All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
N Mounier, C Gisselbrecht, J Brière, et al.
European Journal of Nuclear Medicine
|
February 7, 2001
Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy
C Delcambre, O Reman, M Henry-Amar, et al.
The Journal of Rheumatology
|
August 26, 1998
A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis
D Wendling, E Racadot, J Wijdenes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2009
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
E Terpos, O Sezer, P I Croucher, et al.
La Revue De Medecine Interne
|
August 11, 2015
[Pomalidomide for multiple myeloma]
G Fouquet, M Macro, O Decaux, et al.
Annals of Hematology
|
June 10, 2023
Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study
M Macro, C Hulin, L Vincent, et al.
British Journal of Haematology
|
September 14, 2024
Teclistamab for relapsed refractory multiple myeloma patients on dialysis
P Lebreton, F Lachenal, S Bouillie, et al.
Leukemia
|
July 30, 2011
Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience
H Avet-Loiseau, M Roussel, L Campion, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 27, 2024
Real-Life Management of Patients Aged 80 Years Old and Over With Multiple Myeloma: Results of the EMMY Cohort
T Chalopin, M Macro, O Decaux, et al.
Page
of 6